The immune mechanisms of acute exacerbations of idiopathic pulmonary fibrosis

Front Immunol. 2024 Dec 16:15:1450688. doi: 10.3389/fimmu.2024.1450688. eCollection 2024.

Abstract

Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF) are the leading cause of mortality among patients with IPF. There is still a lack of effective treatments for AE-IPF, resulting in a hospitalization mortality rate as high as 70%-80%. To reveal the complicated mechanism of AE-IPF, more attention has been paid to its disturbed immune environment, as patients with IPF exhibit deficiencies in pathogen defense due to local immune dysregulation. During the development of AE-IPF, the classical stimulatory signals in adaptive immunity are inhibited, while the nonclassical immune reactions (Th17) are activated, attracting numerous neutrophils and monocytes to lung tissues. However, there is limited information about the specific changes in the immune response of AE-IPF. We summarized the immune mechanisms of AE-IPF in this review.

Keywords: Th17; acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF); acute lung injury; immune mechanism; macrophages.

Publication types

  • Review

MeSH terms

  • Adaptive Immunity
  • Animals
  • Disease Progression
  • Humans
  • Idiopathic Pulmonary Fibrosis* / immunology
  • Lung / immunology
  • Lung / pathology
  • Neutrophils / immunology

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This study was financially supported by the National High-Level Hospital Clinical Research Funding (2022-PUMCH-B-108), the National Natural Science Foundation of China (82070067), and the Postdoctoral Fellowship Program of CPSF (GZC20240137).